Exploring the relationships between clinical manifestations and sex hormones, thyroid hormones, and menstrual factors in female Parkinson’s disease patients
Fan Wang(Aerospace Center Hospital), Zhirong Wan(Aerospace Center Hospital), Tao Feng(Capital Medical University), Jing Zhao(Renmin University of China), Peifu Wang(Peking University), Jichen Du(King University), Jilai Li(Aerospace Center Hospital), Yi Zhong(Beijing Geriatric Hospital)
Cited by 0
Related Papers
Pharmacological Modulation of Nrf2/HO-1 Signaling Pathway as a Therapeutic Target of Parkinson’s Disease
|Frontiers in Pharmacology|2021|95
Hypertrophic olivary degeneration: A comprehensive review focusing on etiology
|Brain Research|2019|73
Hybrid federated learning with brain-region attention network for multi-center Alzheimer's disease detection
|Pattern Recognition|2024|58
A comparative study of the amount of α-synuclein in ischemic stroke and Parkinson’s disease
|Neurological Sciences|2016|46
cGAS-STING targeting offers novel therapeutic opportunities in neurological diseases
|Ageing Research Reviews|2025|46